ASBP
Aspire Biopharma Holdings, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Kraig T. Higginson
IPO Date
2025-02-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aspire Biopharma Holdings, Inc.
CEO
Kraig T. Higginson
IPO Date
2025-02-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 10,500 |
| $0.39 |
| 6 Jun 2025 | Fell Donald G. | director | P-Purchase | Disposed | 9,500 | $0.39 |
| 6 Jun 2025 | Fell Donald G. | director | P-Purchase | Disposed | 10,500 | $0.39 |